We are live on ! Find out more
ONCY icon

Oncolytics Biotech

20 hedge funds and large institutions have $282K invested in Oncolytics Biotech in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.21% less ownership

Funds ownership: 1.13% → 0.92% (-0.21%)

5% less funds holding

Funds holding: 21 → 20 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

41% less capital inflows, than outflows

Capital inflows: $165K | Capital outflows: $280K

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ONCY Hedge Fund Activity: Q4 2018 in Review

20 of the 4,504 institutional investors tracked by Wall St. Rank reported a position in Oncolytics Biotech (ONCY) for Q4 2018, worth a combined $282K — down 60% from $707K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ONCY and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.

The largest buyer was Scotia Capital, opening a new position worth an estimated $121K. The largest seller was Millennium Management, exiting entirely with an estimated $180K sold.

  • 20 institutional investors held Oncolytics Biotech (ONCY) as of Q4 2018, down from 21 in Q3 2018.
  • Funds reported $282K of Oncolytics Biotech stock for Q4 2018, down 60% quarter-over-quarter.
  • 4 funds opened new Oncolytics Biotech positions in Q4 2018 and 5 closed out, a net change of -1 holder.
  • The largest Oncolytics Biotech buyer in Q4 2018 was Scotia Capital, an estimated $121K added.
  • The largest Oncolytics Biotech seller in Q4 2018 was Millennium Management, an estimated $180K sold.

Based on aggregated 13F filings for Q4 2018.